SCHEMBL194060

SCHEMBL194060

NC(=O)N(CCCO)CCCO

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
NTRK2 Q16620 1/20 0.36
CAMK2A Q9UQM7 1/20 0.33
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31
GPR84 Q9NQS5 1/20 0.31
FFAR1 O14842 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2843504 0.95 NTRK2 (0.34) NTRK2CAMK2ACA12CA1CA9
SCHEMBL20723734 0.92 GPR84 (0.35) NTRK2CAMK2ACA12CA1CA9
SCHEMBL11498558 0.90 GPR84 (0.39) NTRK2CAMK2AGPR84FFAR1FFAR4
SCHEMBL6828098 0.90 GPR84 (0.39) NTRK2CAMK2AGPR84FFAR1FFAR4
SCHEMBL11317847 0.90 NTRK2 (0.38) NTRK2CAMK2A
SCHEMBL2827083 0.89 CA12 (0.41) NTRK2CA12CA1CA9
SCHEMBL2829319 0.89 CA12 (0.48) CA12CA1CA9
SCHEMBL11313988 0.86 CA12 (0.35) CA12CA1CA9
SCHEMBL1416286 0.85 NTRK2 (0.33) NTRK2
SCHEMBL2829211 0.85 CA12 (0.42) NTRK2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171489-B1 SANITIZING COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-03-25 EP claimed
US-20230255868-A1 SANITIZING COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2023-08-17 US claimed
EP-4171489-A1 SANITIZING COMPOSITION Unilever IP Holdings B.V. (NL) 2023-05-03 EP claimed
CN-115734808-A Disinfecting compositions 联合利华知识产权控股有限公司 2023-03-03 CN claimed
WO-2022002882-A1 SANITIZING COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2022-01-06 WO claimed
WO-2018000059-A1 COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF THE HAIR L'OREAL (FR) 2018-01-04 WO claimed
EP-2836188-B1 EMULSION HAVING UREA DERIVATIVES HENKEL AG & CO KGAA (DE) 2017-11-01 EP claimed
EP-2988830-A2 COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF L'Oréal (FR) 2016-03-02 EP claimed
EP-2916808-A1 COMPOSITION COMPRISING A DICARBONYL DERIVATIVE AND METHOD FOR STRAIGHTENING THE HAIR USING THIS COMPOSITION L'Oréal (FR) 2015-09-16 EP claimed
WO-2014174075-A2 COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF L'OREAL (FR) 2014-10-30 WO claimed
WO-2014072658-A1 COMPOSITION COMPRISING A DICARBONYL DERIVATIVE AND METHOD FOR STRAIGHTENING THE HAIR USING THIS COMPOSITION L'OREAL (FR) 2014-05-15 WO claimed
US-20260090969-A1 COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS Nuchido Limited (GB) 2026-04-02 US disclosed
EP-4171489-B1 SANITIZING COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-03-25 EP disclosed
EP-4547213-B1 ANTI-ACNE COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-01-14 EP disclosed
US-20250375363-A1 ANTI-ACNE COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2025-12-11 US disclosed
WO-2005079740-A1 STABILIZATION WITH SUBSTITUTED UREAS AGAINST COLOR DEGRADATION OF PERSONAL CARE PRODUCTS UNILEVER PLC (GB) 2005-09-01 WO disclosed
US-20050186231-A1 Stabilization with substituted ureas against color degradation of personal care products UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2005-08-25 US disclosed
EP-1212393-A2 FABRIC CARE COMPOSITION CONTAINING POLYCARBOXYLATE POLYMER AND COMPOUND DERIVED FROM UREA COLGATE-PALMOLIVE COMPANY (US) 2002-06-12 EP disclosed
WO-2001016262-A2 FABRIC CARE COMPOSITION CONTAINING POLYCARBOXYLATE POLYMER AND COMPOUND DERIVED FROM UREA COLGATE-PALMOLIVE COMPANY (US) 2001-03-08 WO disclosed
US-5393828-A Chemical degradation of cured amino resins BASF AKTIENGESELLSCHAFT (DE) 1995-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250375363-A1 ANTI-ACNE COMPOSITION EBP, CUTA, LPO NTRK2 3652/4885CAMK2A 4142/4885CA12 4157/4885
US-20260090969-A1 COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS NLN, TFAM, CYP27B1 NTRK2 543/4885CAMK2A 242/4885CA12 3937/4885
US-20050186231-A1 Stabilization with substituted ureas against color degradation of personal care products CUTA, PUF60, USP10 NTRK2 4299/4885CAMK2A 4863/4885CA12 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.